DistressOther

Sorrento Therapeutics, Inc. acquired NANTibody to its invested amount as of June 30, 2017

Name: Sorrento Therapeutics, Inc. acquired NANTibody to its invested amount as of June 30, 2017
Start: 2023-02-13

Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.

Deal tape row

Sorrento Therapeutics, Inc. -> NANTibody to its invested amount as of June 30, 2017 · $90.05 million

Soon-Shiong acquired the drug Cynviloq for the purpose of halting its progression to the market.